Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma.
Durante C, Boukheris H, Dromain C, Duvillard P, Leboulleux S, Elias D, de Baere T, Malka D, Lumbroso J, Guigay J, Schlumberger M, Ducreux M, Baudin E.
Durante C, et al. Among authors: elias d.
Endocr Relat Cancer. 2009 Jun;16(2):585-97. doi: 10.1677/ERC-08-0301. Epub 2009 Feb 24.
Endocr Relat Cancer. 2009.
PMID: 19240182
Clinical Trial.